Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Autologous epidermal cell suspensions speed up healing and reduce complications in skin lesion treatment but have limited impact on cosmetic outcomes.

The document's conclusion cannot be provided because the content is not accessible.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Rituximab improved her dermatomyositis better than usual treatments.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Immune therapy for cancer can cause hair loss scars in some patients.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Generic topical and transdermal systems usually cause minimal irritation or sensitization.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

RCS-01 cell therapy is safe and improves skin gene expression.

Early diagnosis and treatment are crucial for skin emergencies and drug reactions.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

IL-17 and IL-23 inhibitors can cause skin reactions that may require different treatments.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

Tofacitinib can cause a rare rash called SDRIFE, which resolves after stopping the drug.

Systemic sclerosis skin shows varied gene patterns, suggesting potential for personalized treatment.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Patients with skin immune diseases need better education on UV protection to improve compliance.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.